Division of Pharmacoepidemiology and Pharmacoeconomics
Department of Medicine
Brigham and Women's Hospital and Harvard Medical School
Department of Medicine
Brigham and Women's Hospital and Harvard Medical School
MISSION
The mission of the Program on the Pharmacoepidemiology of Metabolic Diseases (PROMISE) is to advance the understanding of the treatments for cardio-metabolic-renal diseases in clinical practice, in order to inform medical prescribing and improve patient care.
WHAT WE DO & WHO WE ARE
We study utilization, safety, effectiveness, and cost-effectiveness of treatment strategies among patients with cardio-metabolic-renal diseases in clinical practice, through the use of cutting-edge epidemiologic and statistical methods, leveraging one of the nation’s largest data repository of longitudinal healthcare data to conduct pharmacoepidemiologic research in cardio-metabolic-renal diseases, including claims data for over 200 million lives, registries, and electronic health records, and innovative linkage of different databases. PROMISE includes a multidisciplinary team with expertise in pharmacoepidemiology, statistics, endocrinology, nephrology, cardiology, and obesity medicine, and trains the next generation of researchers in pharmacoepidemiology of cardio-metabolic-renal diseases from around the world.
The mission of the Program on the Pharmacoepidemiology of Metabolic Diseases (PROMISE) is to advance the understanding of the treatments for cardio-metabolic-renal diseases in clinical practice, in order to inform medical prescribing and improve patient care.
WHAT WE DO & WHO WE ARE
We study utilization, safety, effectiveness, and cost-effectiveness of treatment strategies among patients with cardio-metabolic-renal diseases in clinical practice, through the use of cutting-edge epidemiologic and statistical methods, leveraging one of the nation’s largest data repository of longitudinal healthcare data to conduct pharmacoepidemiologic research in cardio-metabolic-renal diseases, including claims data for over 200 million lives, registries, and electronic health records, and innovative linkage of different databases. PROMISE includes a multidisciplinary team with expertise in pharmacoepidemiology, statistics, endocrinology, nephrology, cardiology, and obesity medicine, and trains the next generation of researchers in pharmacoepidemiology of cardio-metabolic-renal diseases from around the world.
|
Division of Pharmacoepidemiology & Pharmacoeconomics
Department of Medicine Brigham & Women's Hospital and Harvard Medical School 1620 Tremont Street Suite 3030 Boston, MA 02120 |
|